Flagship Biosciences to exhibit at SITC Annual Meeting 2016 with two immune cell analysis posters

Booth #127 November 11-13, National Harbor, MD National Harbor, MD – Nov. 2 2016 – Flagship Biosciences, the leader in tissue image analysis, announced today that they will be presenting new data at the Annual Meeting of the Society for Immunotherapy of Cancer being held November 11-13, with exhibits from Nov. 11-12. Flagship’s scientists will […]

Read More

Flagship’s computational Tissue Analysis (cTA™) tools support Summit’s DMD drug development

Flagship develops cTA™ tools and duplex IHC assays for muscle biopsy evaluation in support of disease-modifying therapies for Duchenne muscular dystrophy Granada, Spain – October 18th, 2016 – Data and findings featuring Flagship’s computational Tissue Analysis (cTA™) in the development of biomarker analysis tools to support Duchenne muscular dystrophy (DMD) drug development were presented by […]

Read More

Flagship Biosciences to exhibit at ASCO Annual Meeting 2016

Booth #19122 June 3-7, McCormick Place, Chicago, IL May 25, 2016 – Westminster, CO – Flagship Biosciences, the leader in tissue image analysis, announced today that they will be exhibiting at the American Society for Clinical Oncology (ASCO) at McCormick Place in Chicago, IL for the ASCO Annual Meeting being held June 3rd to June […]

Read More

Dr. Nancy Gillett Joins Flagship's Board of Directors

Former Charles River Laboratories CSO broadens Flagship’s leadership expertise Westminster, CO – May 3, 2016 – Flagship Biosciences, the leader in tissue image analysis, announced the addition of Dr. Nancy Gillett to its Board of Directors. Dr. Gillett recently retired from Charles River Laboratories (CRL), where, in her last position, she served as Corporate Executive […]

Read More

Flagship to exhibit at AACR Annual Meeting 2016 with three immuno-oncology presentations

Booth #2634, April 16-20, Ernest N. Memorial Convention Center, New Orleans, LA Westminster, CO – April 13, 2016 – Flagship is pleased to announce that they will be exhibiting at the AACR Annual Meeting in New Orleans from April 16th-20th. AACR’s Annual meeting is one of the largest oncology conferences bringing together cancer researchers and […]

Read More

Flagship Biosciences expands operations to meet tremendous industry growth demands

Escalated demand for Flagship’s tissue analysis capabilities are being driven by proven success. Westminster, CO – March 15, 2016 – Flagship’s track record of success has increased the adoption of the company’s technology and the demand for their specialty tissue image analysis solutions. To meet this demand, the company has expanded its facilities and staff, […]

Read More

Flagship Biosciences and Beaufort, LLC partner to provide Clinical Trial Services for the Pharmaceutical Industry

Flagship Biosciences establishes partnership with Beaufort, an industry-leading CRO, to provide a full range of clinical trial services to advance initiatives that bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – February 2, 2016 – Flagship Biosciences, Inc. announces that Beaufort, LLC., www.beaufortcro.com, an industry leading diagnostic-CRO with extensive experience […]

Read More

Flagship Creates Clinical Trials and Regulatory Affairs Group

Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – January 19th, 2016 – Flagship Biosciences has created a Clinical Trials and Regulatory Affairs group and partners […]

Read More

Quality Management System for the development of Medical Device Software

Flagship Biosciences establishes a Quality Management System (QMS) for the development of medical device software to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – October 27, 2015 – Flagship Biosciences’ Software Development Department has established a Quality Management System (QMS) for the development of medical device software in compliance […]

Read More

Flagship launches new website to highlight areas of clinical focus

Denver, CO – Oct 20, 2015 – Flagship Biosciences, the largest tissue image analysis provider for the drug development industry, is pleased to announce a website redesign, which highlights our advanced technology and clinical readiness needed to support image analysis based companion diagnostic strategies for the pharmaceutical industry. Flagship’s growth has been accelerated by the […]

Read More